What is the price target for AIM stock?
5 analysts have analysed AIM and the average price target is 22.42 USD. This implies a price increase of 2342% is expected in the next year compared to the current price of 0.918.
AIM IMMUNOTECH INC (AIM) Forecast, Price Target & Analyst Ratings
NYSEARCA:AIM • US00901B3033
Current stock price
0.918 USD
-0.1 (-10%)
At close:
0.9361 USD
+0.02 (+1.97%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for AIM IMMUNOTECH INC (AIM).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- Mar 30, 2026
- Period
- Q4 / 2025
- EPS Estimate
- -$0.97
- Revenue Estimate
Price Target Details & History
Consensus Price Target and Range
Mean target
$22.42
Upside
+ 2,342.00%
From current price of $0.92 to mean target of $22.42, Based on 5 analyst forecasts
Low
$22.20
Median
$22.42
High
$23.08
Price Target Revisions
1 Month
0.00%
3 Months
-8.43%
Price Target Summary
5 Wall Street analysts provided a forecast for the next 12 months for AIM. The average price target is 22.42 USD. This implies a price increase of 2342% is expected in the next year compared to the current price of 0.918.
The average price target has been revised downward by 8.43% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
80.00%
AIM was analyzed by 5 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about AIM.
In the previous month the buy percentage consensus was at a similar level.
Only 5 analysts analyzed AIM. So this is just the average opinion of a couple of analysts.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-12-08 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2025-10-03 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2024-12-10 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2024-10-22 | Maxim Group | Maintains | Buy -> Buy |
| 2024-09-03 | Ascendiant Capital | Maintains | Buy -> Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Mar 30, 2026
- Period
- Q4 / 2025
- EPS Estimate
- -$0.97
- Revenue Estimate
- Revenue Q2Q
- -100.00%
- EPS Q2Q
- 90.26%
- Number of Analysts
- 3
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
0.10%
Next Earnings Summary
AIM is expected to report earnings on 3/30/2026. The consensus EPS estimate for the next earnings is -0.97 USD and the consensus revenue estimate is 0 USD.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 141K 4.44% | 202K 43.26% | 170K -15.84% | 71.205K -58.11% | 101K 41.84% | 9.848M 9,650.50% | -100.00% | 24.561M | 52.817M 115.04% | 95.51M 80.83% | 163.75M 71.45% | ||
| EBITDA YoY % growth | -19.667M -20.77% | -31.678M -61.07% | -19.526M 38.36% | 57.57M 394.84% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -19.923M -16.79% | -31.916M -60.20% | -19.772M 38.05% | -11.662M 41.02% | -12.223M -4.80% | -14.679M -20.10% | -8.79M 40.12% | 43.5M 594.88% | 128.74M 195.95% | 194.1M 50.77% | 245.06M 26.25% | N/A | |
| Operating Margin | -14,129.79% | -15,800.00% | -11,630.59% | -16,378.72% | -12,101.50% | -149.06% | N/A | N/A | 524.16% | 367.50% | 256.58% | N/A | |
| EPS YoY % growth | -40.00 | -60.00 -50.00% | -32.40 46.00% | -7.36 77.30% | -3.32 54.80% | -1.62 51.14% | -0.12 92.54% | 0.59 583.33% | 1.74 196.55% | 2.56 47.09% | 3.11 21.74% | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.97 90.26% | -0.81 83.84% | -0.82 77.75% | -0.84 46.23% | -0.85 12.35% | -0.64 21.17% | -0.34 58.02% | -0.30 64.07% | -0.38 55.03% |
| Revenue Q2Q % growth | -100.00% | -100.00% | -100.00% | -100.00% | N/A | N/A | N/A | N/A | |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -2.748M 53.07% | -2.948M 18.54% | -3.008M -13.69% | -3.128M -14.98% | -3.189M -16.04% | -3.376M -14.53% | -3.523M -17.11% | -3.817M -22.00% | -3.963M -24.30% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
24.93%
EPS Next 5 Year
15.08%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
306.65%
Revenue Next 5 Year
-14.87%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
AIM IMMUNOTECH INC / AIM Forecast FAQ
What is the next earnings date for AIM stock?
AIM IMMUNOTECH INC (AIM) will report earnings on 2026-03-30, after the market close.
Can you provide the consensus estimates for AIM IMMUNOTECH INC next earnings?
The consensus EPS estimate for the next earnings of AIM IMMUNOTECH INC (AIM) is -0.97 USD and the consensus revenue estimate is 0 USD.
What is the number of analysts for AIM stock?
The number of analysts covering AIM IMMUNOTECH INC (AIM) is 5.